Presepsin (sCD14-ST), an innate immune response marker in sepsis

Clinica Chimica Acta

Volumn 450, Issue , 2015, Pages 97-103

  Chenevier Gobeaux, Camille ^a   Borderie, Didier ^a,b   Weiss, Nicolas ^c   Mallet Coste, Thomas ^c   Claessens, Yann Erick ^c  

^a université Paris Cité   (France)

^b Centre Universitaire des Saints Pères   (France)

^c CENTRE HOSPITALIER PRINCESSE GRACE   (Monaco)

Author keywords

Biomarker; Infection; Presepsin; SCD14 ST; Sepsis; Soluble subtype of CD14

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD14 ANTIGEN; INTERLEUKIN 6; PRESEPSIN; PROCALCITONIN; UNCLASSIFIED DRUG; PEPTIDE FRAGMENT; PRESEPSIN PROTEIN, HUMAN;

CANDIDEMIA; CYTOKINE RELEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTION; HOST PATHOGEN INTERACTION; HUMAN; INFECTIOUS DISEASE CLIA; INNATE IMMUNITY; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; STAPHYLOCOCCUS INFECTION; COMMUNICABLE DISEASES; IMMUNOLOGY;

ANTIGENS, CD14; BIOMARKERS; COMMUNICABLE DISEASES; HUMANS; IMMUNITY, INNATE; PEPTIDE FRAGMENTS; SEPSIS;

EID: 84939439014     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.06.026     Document Type: Review

References (48)

1. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
2. Pierrakos C., Vincent J.L. Sepsis biomarkers: a review. Crit. Care 2010, 14:R15.
3. Nakamura M., Takeuchi T., Naito K., Shirakawa K., Hosaka Y., Yamasaki F., Furusako S. Early elevation of plasma soluble CD14 subtype, a novel biomarker for sepsis, in a rabbit cecal ligation and puncture model. Crit. Care 2008, 12:P194.
4. Luzzani A1., Polati E., Dorizzi R., Rungatscher A., Pavan R., Merlini A. Comparison of procalcitonin and C-reactive protein as markers of sepsis. Crit. Care Med. 2003, 31:1737-1741.
5. Tang B.M., Eslick G.D., Craig J.C., McLean A.S. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect. Dis. 2007, 7:210-217.
6. Medzhitov R., Janeway C. Innate immunity. N. Engl. J. Med. 2000, 343:338-344.
7. Okamura Y., Yokoi H. Development of a point-of-care assay system for measurement of presepsin (sCD14-ST). Clin. Chim. Acta 2011, 412:2157-2161.
8. Hancock R. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 2001, 1:156-164.
9. Modlin R., Brightbill H., Godowski P. The toll of innate immunity on microbial pathogens. N. Engl. J. Med. 1999, 340:1834-1835.
10. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
11. Jack R.S., Fan X., Bernheiden M., Rune G., Ehlers M., Weber A., Kirsch G., Mentel R., Fürll B., Freudenberg M., Schmitz G., Stelter F., Schütt C. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Nature 1997, 389:742-745.
12. Zanoni I., Ostuni R., Marek L.R., Barresi S., Barbalat R., Barton G.M., Granucci F., Kagan J.C. CD14 controls the LPS-induced endocytosis of Toll-like receptor 4. Cell 2011, 147:868-880.
13. Poussin C., Foti M., Carpentier J.L., Pugin J. CD-14 dependent endotoxin internalization via a macropinocytic pathway. J. Biol. Chem. 1998, 273:20285-20291.
14. Le-Barillec K., Si-Tahar M., Balloy V., Chignard M. Proteolysis of monocyte CD14 by human leukocyte elastase inhibits lipopolysaccharide-mediated cell activation. J. Clin. Invest. 1999, 103:1039-1046.
15. Landmann R., Reber A.M., Sansano S., Zimmerli W. Function of soluble CD14 in serum from patients with septic shock. J. Infect. Dis. 1996, 173:661-668.
16. Pavcnik-Arnol M., Hojker S., Derganc M. Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children. Intensive Care Med. 2007, 33:1025-1032.
17. Berner R., Fürll B., Stelter F., Dröse J., Müller H.P., Schütt C. Elevated levels of lipopolysaccharide-binding protein and soluble CD14 in plasma in neonatal early-onset sepsis. Clin. Diagn. Lab. Immunol. 2002, 9:440-445.
18. Kitchens R.L., Wang P.Y., Munford R.S. Bacterial lipopolysaccharide can enter monocytes via two CD14-dependent pathways. J. Immunol. 1998, 161:5534-5545.
19. Mussap M., Noto A., Fravega M., Fanos V. Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers. J. Matern. Fetal Neonatal Med. 2011, 24:12-14.
20. Rey Nores J.E., Bensussan A., Vita N., Selter F., Arias M.A., Jones M., Lefort S., Borysiewicz L.K., Ferrara P., Labéta M.O. Soluble CD14 acts as a negative regulator of humanT cell activation and function. Eur. J. Immunol. 1999, 29:265-286.
21. Landmann R., Zimmerli W., Sansano S., Link S., Hahn A., Glauser M.P., Calandra T. Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J. Infect. Dis. 1995, 171:639-644.
22. Yaegashi Y., Shirakawa K., Sato N., Suzuki Y., Kojika M., Imai S., Takahashi G., Miyata M., Furusako S., Endo S. Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis. J. Infect. Chemother. 2005, 11:234-238.
23. Shirakawa K., Naitou K., Hirose J., Takahashi T., Furusako S. Presepsin (sCD14-ST): development and evaluation of one-step ELISA with a new standard that is similar to the form of presepsin in septic patients. Clin. Chem. Lab. Med. 2011, 49:937-939.
24. Chenevier-Gobeaux C., Bardet V., Poupet H., Poyart H., Borderie D., Claessens Y.E. Presepsin (sCD14-ST) secretion and kinetics by peripheral blood mononuclear cells and monocytic THP-1 cell line. Ann. Biol. Clin. (Paris) 2014, (in press).
25. Shozushima T., Takahashi G., Matsumoto N., Kojika M., Okamura Y., Endo S. Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome. J. Infect. Chemother. 2011, 17:764-769.
26. Claessens Y.E., Trabattoni E., Grabar S., Quinquis L., Der Sahakian G., Anselmo M., Schmidt J., de la Coussaye J.E., Gayet A., Casalino E., Batard E., Lecomte F., Borderie D., Chenevier-Gobeaux C. Plasmatic presepsin (sCD14-ST) concentrations in acute pyelonephritis in adult patients. Crit. Care 2013, (in press).
27. Liu B., Chen Y.X., Yin Q., Zhao Y.Z., Li C.S. Diagnostic value and prognostic evaluation of presepsin for sepsis in an emergency department. Crit. Care 2013, 17:R244.
28. Chenevier-Gobeaux C., Trabattoni E., Roelens M., Borderie D., Claessens Y.E. Presepsin (sCD14-ST) in emergency department: the need for adapted threshold values?. Clin. Chim. Acta 2014, 427:34-36.
29. Behnes M., Bertsch T., Lepiorz D., Lang S., Trinkmann F., Brueckmann M., Borggrefe M., Hoffmann U. Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. Crit. Care 2014, 18:507.
30. Kweon O.J., Choi J.H., Park S.K., Park A.J. Usefulness of presepsin (sCD14 subtype) measurements as a new marker for the diagnosis and prediction of disease severity of sepsis in the Korean population. J. Crit. Care 2014, 29:965-970.
31. Mussap M., Puxeddu E., Burrai P., Noto A., Cibecchini F., Testa M., Puddu M., Ottonello G., Dessi A., Irmesi R., Dalla Gassa E., Fanni C., Fanos V. Soluble CD14 subtype (sCD14-ST) presepsin in critically ill preterm newborns: preliminary reference ranges. J. Matern. Fetal Neonatal Med. 2012, 25:51-53.
32. Malíčková K., Koucký M., Pařízek A., Pelinková K., Brodská H., Hájek Z., Germanová A., Mestek O., Zima T. Diagnostic and prognostic value of presepsin in preterm deliveries. J. Matern. Fetal Neonatal Med. Jul 28 2014, 1-6.
33. Ulla M., Pizzolato E., Lucchiari M., Loiacono M., Soardo F., Forno D., Morello F., Lupia E., Moiragho C., Mengozzi G., Battista S. Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit. Care 2013, 17:R16.
34. Ishikura H., Nishida T., Murai A., Nakamura Y., Irie Y., Tanaka J., Umemura T. New diagnostic strategy for sepsis-induced disseminated intravascular coagulation: a prospective single-center observational study. Crit. Care 2014, 18:R19.
35. Romualdo L.G., Torrella P.E., González M.V., Sánchez R.J., Holgado A.H., Freire A.O., Acebes S.R., Otón M.D. Diagnostic accuracy of presepsin (soluble CD14 subtype) for prediction of bacteremia in patients with systemic inflammatory response syndrome in the Emergency Department. Clin. Biochem. 2014, 47:505-508.
36. Cakir Madenci Ö., Yakupoğlu S., Benzonana N., Yücel N., Akbaba D., Orçun Kaptanağasi A. Evaluation of soluble CD14 subtype (presepsin) in burn sepsis. Burns 2014, 40:664-669.
37. Mallet-Coste T., Chenevier-Gobeaux C., Fissore-Magdelein C., Magdelein X., Brod F., Claessens Y.E. Presepsin (sCD14-ST), an emergent and promising biomarker of infection. Ann. Fr. Med. Urgence 2013, 3:305-309. (article in French).
38. Clerico A., Giannoni A., Prontera C., Giovannini S. High-sensitivity troponin: a new tool for pathophysiological investigation and clinical practice. Adv. Clin. Chem. 2009, 49:1-30.
39. Januzzi J.L., van Kimmenade R., Lainchbury J., Bayes-Genis A., Ordonez-Llanos J., Santalo-Bel M., Pinto Y.M., Richards M. NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study. Eur. Heart J. 2006, 27:330-337.
40. Thygesen K., Mair J., Giannitsis E., Mueller C., Lindahl B., Blankenberg S., Huber K., Plebani M., Biasucci L.M., Tubaro M., Collinson P., Venge P., Hasin Y., Galvani M., Koenig W., Hamm C., Alpert J.S., Katus H., Jaffe A.S., Study Group on Biomarkers in Cardiology of ESC Working Group on Acute Cardiac Care How to use high-sensitivity cardiac troponins in acute cardiac care. Eur. Heart J. 2012, 33:2252-2257.
41. Palmiere C., Mussap M., Bardy D., Cibecchini F., Mangin P. Diagnostic value of soluble CD14 subtype (sCD14-ST) presepsin for the post-mortem diagnosis of sepsis-related fatalities. Int. J. Legal Med. 2013, 127:799-808.
42. Masson S., Caironi P., Spanuth E., Thomae R., Panigada M., Sangiorgi G., Fumagalli R., Mauri T., Isgrò S., Fanizza C., Romero M., Tognoni G., Latini R., Gattinoni L. Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis; data from the Albumin Italian Outcome Sepsis trial. Crit. Care 2014, 18:R6.
43. Rabensteiner J., Skvarc M., Hoenigl M., Osredkar J., Prueller F., Reichsoellner M., Krause R., Raggam R.B. Diagnostic and prognostic potential of presepsin in Emergency Department patients presenting with systemic inflammatory response syndrome. J. Infect. 2014, 69:627-630.
44. Endo S., Suzuki Y., Takahashi G., Shozushima T., Ishikura H., Murai A., Nishida T., Irie Y., Miura M., Iguchi H., Fukui Y., Tanaka K., Nojima T., Okamura Y. Presepsin as a powerful monitoring tool for the prognosis and treatment of sepsis: a multicenter prospective study. J. Infect. Chemother. 2014, 20:30-34.
45. Liu B., Yin Q., Chen Y.X., Zhao Y.Z., Li C.S. Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department. Respir. Med. 2014, 108:1204-1213.
46. Nakamura A., Wada H., Ikejiri M., Hatada T., Sakurai H., Matsushima Y., Nishioka J., Maruyama K., Isaji S., Takeda T., Nobori T. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unite. Shock 2009, 31:591.
47. Takahashi G., Shibata S., Ishikura H., Miura M., Fukui Y., Inoue Y., Endo S. Presepsin in the prognosis of infectious diseases and diagnosis of infectious disseminated intravascular coagulation: a prospective, multicentre, observational study. Eur. J. Anaesthesiol. 2015, 32:199-206.
48. Poggi C., Bianconi T., Gozzini E., Generoso M., Dani C. Presepsin for the detection of late-onset sepsis in preterm newborns. Pediatrics 2015, 135:68-75.